We may anticipate or factor in COVID-19 affect the data/results we are waiting for given its relatively short incubation period and ease of contraction and also the fact that the patients will already have a compromised immune system and likely already in the high risk category. If that is the case, then the data (affected cases) should be explained and IF the patients on the real drug (efti) are not affected by the virus or survived the virus if contracted, then that in itself is very much worth the emphasis.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $379.7M | |||
| Open | High | Low | Value | Volume |
| 26.0¢ | 27.0¢ | 26.0¢ | $1.129M | 4.264M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 31426 | 26.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.5¢ | 37000 | 1 |
View Market Depth
| Last trade - 16.11pm 18/07/2025 (20 minute delay) ? |
| IMM (ASX) Chart |